Laurence Digue

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

Ezra E.W. Cohen, Denis Soulières, Christophe Le Tourneau et al. · The Lancet · 2018 · 1.6K citations · Full text

Medicine, Pathology, Head And Neck Cancer +5

Positron Emission Tomography With [¹⁸F]Fluorodeoxyglucose Improves Staging and Patient Management in Patients With Head and Neck Squamous Cell Carcinoma: A Multicenter Prospective Study

Max Lonneux, Marc Hamoir, H Reychler et al. · Journal of Clinical Oncology · 2010 · 228 citations · Full text

Oncologic Imaging, Pet-mri, Pathology +20

Impact of the prophylactic gastrostomy for unresectable squamous cell head and neck carcinomas treated with radio-chemotherapy on quality of life: Prospective randomized trial

Sébastien Salas, Karine Baumstarck, M. Alfonsi et al. · Radiotherapy and Oncology · 2009 · 122 citations

Prophylactic Gastrostomy, Radiation Therapy, Medicine +9

A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study

Alain Ravaud, Christelle de la Fouchardière, Philippe Caron et al. · European Journal of Cancer · 2017 · 107 citations

Thysu Study, Medicine, Medullary Thyroid Carcinomas +7

Evaluation of the genotoxic activity of paclitaxel by the in vitro micronucleus test in combination with fluorescent in situ hybridization of a DNA centromeric probe and the alkaline single cell gel electrophoresis technique (comet assay) in human T-lymphocytes

Laurence Digue, T. Orsi�re, Min Mo et al. · Environmental and Molecular Mutagenesis · 1999 · 76 citations